Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B. and Essler, M. (2018). Lutetium-177-PSMA radioligand therapy. Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Dusseldorf, Essen, and Cologne and the MDK Nordrhein. Urologe, 57 (6). S. 709 - 714. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Brandt, Maximilian Peter, Ruf, C., Dieckmann, K. P., Syring, I, Ruckes, C., Nestler, T., Schmelz, H. U., Dotzauer, R., Hiester, A., Albers, P., Nettersheim, D., Bolenz, C., Loosen, S. H., Heidenreich, A., Pfister, D., Haferkamp, A., Zengerling, F. and Paffenholz, P. (2022). Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer. World J. Urol., 40 (2). S. 327 - 335. NEW YORK: SPRINGER. ISSN 1433-8726

Gschwend, J. E., Albers, P., Boegemann, M., Goebell, P., Heidenreich, A., Klier, J., Koenig, F., Machtens, S., Pantel, K. and Thomas, C. (2018). Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data. Urologe, 57 (1). S. 34 - 40. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Hiester, A., Paffenholz, P., Albers, P., Heidenreich, A. and Pfister, D. . Importance of residual tumor resection and desperation surgery in advanced germ cell tumors. Onkologe. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Miller, K., Albers, P., Eichenauer, R., Geiges, G., Grimm, M-O., Koenig, F., Mickisch, G., Pfister, D., Schwentner, C., Suttmann, H. and Zastrow, S. (2016). Metastatic castration-resistant prostate cancer. Clinical data, new treatment options and therapy monitoring. Urologe, 55 (9). S. 1206 - 1213. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

This list was generated on Tue Nov 26 05:56:29 2024 CET.